{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T23:02:29Z","timestamp":1790377349612,"version":"4.1.0"},"reference-count":25,"publisher":"Walter de Gruyter GmbH","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Earlier tissue-based studies report heterogeneous CYP and GST protein expression in non-small cell lung cancer (NSCLC), but simultaneous assessment of phase I and II enzymes in paired tumour and peripheral normal tissues remains limited and their expression patterns poorly characterised across the two major NSCLC histological subtypes, namely adenocarcinoma (AC) and squamous cell carcinoma (SCC). To address these gaps, this retrospective study evaluated CYP1A1, CYP1B1, CYP2E1, GSTM1, GSTT1, and GSTP1 expression immunohistochemically in tumour and peripheral normal lung tissues of 50 patients with NSCLC, 27 of whom with AC and 23 with SCC. Cytoplasmic staining intensity was scored from 0 to 3. Tissue and subtype comparisons were performed using the Mann-Whitney\n                    <jats:italic>U<\/jats:italic>\n                    test, and associations with clinical variables were assessed using Spearman's rank correlation. CYP2E1 expression was significantly higher in tumour than in normal tissue in the combined NSCLC group and in both histological subtypes (p&lt;0.05). CYP1A1 expression was higher in AC tumours than in normal tissue and SCC tumours (both p&lt;0.05). GSTM1 expression was higher in tumour tissue in the combined NSCLC group and in the SCC subgroup and was also higher in SCC than in AC tumours (p&lt;0.05). GSTT1 expression was higher in AC than SCC tumours (p&lt;0.05). CYP1B1 and GSTP1 were highly expressed in both tissue compartments but showed no significant tumour-specific increase. CYP and GST isoenzymes therefore showed tissue- and subtype-dependent rather than uniform expression patterns in NSCLC. The differences observed in CYP2E1, CYP1A1, GSTM1, and GSTT1 suggest that AC and SCC may differ in xenobiotic metabolism and cellular defence, and that these isoenzymes may contribute to metabolic processes associated with NSCLC pathogenesis.\n                  <\/jats:p>","DOI":"10.2478\/aiht-2026-77-4112","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:52:51Z","timestamp":1790376771000},"page":"190-197","source":"Crossref","is-referenced-by-count":0,"title":["Tissue-specific variability in protein expression of cytochrome P450 and glutathione S-transferase isoenzymes in non-small cell lung carcinoma"],"prefix":"10.2478","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1377-2021","authenticated-orcid":false,"given":"Murat","family":"K\u0131l\u0131\u00e7","sequence":"first","affiliation":[{"name":"Ankara University Vocational School of Health Services , Department of Pharmacy Services , Ankara , Turkey"},{"name":"K\u0131r\u0131kkale University Faculty of Arts and Sciences , Department of Biology , K\u0131r\u0131kkale , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serpil","family":"O\u011fuzt\u00fcz\u00fcn","sequence":"additional","affiliation":[{"name":"K\u0131r\u0131kkale University Faculty of Arts and Sciences , Department of Biology , K\u0131r\u0131kkale , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sezgin","family":"\u00c7elik","sequence":"additional","affiliation":[{"name":"Y\u0131ld\u0131z Technical University Faculty of Arts and Sciences , Department of Molecular Biology and Genetics , \u0130stanbul , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Funda","family":"Demira\u011f","sequence":"additional","affiliation":[{"name":"University of Health Sciences, Ankara Atat\u00fcrk Sanatorium Training and Research Hospital , Department of Pathology , Ankara , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u0131nar","family":"B\u0131\u00e7ak\u00e7\u0131o\u011flu","sequence":"additional","affiliation":[{"name":"University of Health Sciences, Ankara Atat\u00fcrk Sanatorium Training and Research Hospital , Department of Thoracic Surgery , Ankara , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00fcmtaz","family":"\u0130\u015fcan","sequence":"additional","affiliation":[{"name":"Cyprus International University Faculty of Pharmacy , Department of Pharmaceutical Toxicology , Nicosia , Northern Cyprus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet O\u011fuz","family":"Ada","sequence":"additional","affiliation":[{"name":"Ankara University Faculty of Pharmacy , Department of Pharmaceutical Toxicology , Ankara , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"key":"2026092522522642961_j_aiht-2026-77-4112_ref_001","doi-asserted-by":"crossref","unstructured":"Murray GI. The role of cytochrome P450 in tumour development and progression and its potential in therapy. J Pathol 2000;192:419\u201326. doi: 10.1002\/1096-9896(2000)9999:9999:<::AID-PATH750>3.0.CO;2-0","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH750>3.0.CO;2-0"},{"key":"2026092522522642961_j_aiht-2026-77-4112_ref_002","doi-asserted-by":"crossref","unstructured":"Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxicol 2005;45:51\u201388. doi: 10.1146\/annurev.pharmtox.45.120403.095857","DOI":"10.1146\/annurev.pharmtox.45.120403.095857"},{"key":"2026092522522642961_j_aiht-2026-77-4112_ref_003","doi-asserted-by":"crossref","unstructured":"Wang Z, Wu Y, Ding Z, Xiao X, Huang Y, Liu Z, Zhang Q. A novel mechanism for A-to-I RNA-edited CYP1A1 in promoting cancer progression in NSCLC. Cell Mol Biol Lett 2025;30(1):40. doi: 10.1186\/s11658-025-00718-6","DOI":"10.1186\/s11658-025-00755-1"},{"key":"2026092522522642961_j_aiht-2026-77-4112_ref_004","doi-asserted-by":"crossref","unstructured":"Pan J, Huang G, Yin Z, Cai X, Gong E, Li Y, Xu C, Ye Z, Cao Z, Cheng W. Circular RNA FLNA acts as a sponge of miR-486-3p in promoting lung cancer progression via regulating XRCC1 and CYP1A1. Cancer Gene Ther 2022;29:101\u201321. doi: 10.1038\/s41417-021-00293-w","DOI":"10.1038\/s41417-021-00293-w"},{"key":"2026092522522642961_j_aiht-2026-77-4112_ref_005","doi-asserted-by":"crossref","unstructured":"Gong E, Pan J, Ye Z, Cai X, Zheng H, Yin Z, Jiang Y, Wang X, Cao Z. Ganoderic acid A suppresses autophagy by regulating the circFLNA\/miR-486-3p\/CYP1A1\/XRCC1 axis to strengthen the sensitivity of lung cancer cells to cisplatin. J Pharm Pharmacol 2024;76:354\u201367. doi: 10.1093\/jpp\/rgad116","DOI":"10.1093\/jpp\/rgad116"},{"key":"2026092522522642961_j_aiht-2026-77-4112_ref_006","doi-asserted-by":"crossref","unstructured":"Lin H, Hu B, He X, Mao J, Wang Y, Wang J, Zhang T, Zheng J, Peng Y, Zhang F. Overcoming Taxol-resistance in A549 cells: A comprehensive strategy of targeting P-gp transporter, AKT\/ERK pathways, and cytochrome P450 enzyme CYP1B1 by 4-hydroxyemodin. Biochem Pharmacol 2020;171:113733. doi: 10.1016\/j.bcp.2019.113733","DOI":"10.1016\/j.bcp.2019.113733"},{"key":"2026092522522642961_j_aiht-2026-77-4112_ref_007","doi-asserted-by":"crossref","unstructured":"Oyama T, Sugio K, Uramoto H, Kawamoto T, Kagawa N, Nadaf S, Carbone D, Yasumoto K. Cytochrome P450 expression (CYP) in non-small cell lung cancer. Front Biosci 2007;12:2299\u2013308. doi: 10.2741\/2232","DOI":"10.2741\/2232"},{"key":"2026092522522642961_j_aiht-2026-77-4112_ref_008","unstructured":"Toussaint C, Albin N, Massaad L, Grunenwald D, Parise O Jr, Morizet J, Gouyette A, Chabot GG. Main drug- and carcinogen-metabolizing enzyme systems in human non-small cell lung cancer and peritumoral tissues. Cancer Res 1993;53:4608\u201312. PMID: 8402635"},{"key":"2026092522522642961_j_aiht-2026-77-4112_ref_009","doi-asserted-by":"crossref","unstructured":"Lin P, Chang H, Ho WL, Wu MH, Su JM. Association of aryl hydrocarbon receptor and cytochrome P4501B1 expressions in human non-small cell lung cancers. Lung Cancer 2003;42:255\u201361. doi: 10.1016\/S0169-5002(03)00359-3","DOI":"10.1016\/S0169-5002(03)00359-3"},{"key":"2026092522522642961_j_aiht-2026-77-4112_ref_010","doi-asserted-by":"crossref","unstructured":"Kivist\u00f6 KT, Linder A, Friedel G, Beaune P, Belloc C, Kroemer HK, Fritz P. Immunohistochemical localization of cytochrome P450 2E1 in human pulmonary carcinoma and normal bronchial tissue. Virchows Arch 1995;426:243\u20137. doi: 10.1007\/BF00191361","DOI":"10.1007\/BF00191361"},{"key":"2026092522522642961_j_aiht-2026-77-4112_ref_011","unstructured":"Spivack SD, Hurteau GJ, Fasco MJ, Kaminsky LS. Phase I and II carcinogen metabolism gene expression in human lung tissue and tumors. Clin Cancer Res 2003;9(16 Pt 1):6002\u201311. PMID: 14676126"},{"key":"2026092522522642961_j_aiht-2026-77-4112_ref_012","doi-asserted-by":"crossref","unstructured":"Sobin LH, Wittekind C, editors. TNM Classification of Malignant Tumours. 6th ed. New York (NY): Wiley-Liss; 2002.","DOI":"10.1002\/0471463752"},{"key":"2026092522522642961_j_aiht-2026-77-4112_ref_013","doi-asserted-by":"crossref","unstructured":"Sobin LH, Gospodarowicz MK, Wittekind C, editors. TNM Classification of Malignant Tumours. 7th ed. Chichester: Wiley-Blackwell; 2009.","DOI":"10.1002\/9780471420194.tnmc26.pub2"},{"key":"2026092522522642961_j_aiht-2026-77-4112_ref_014","doi-asserted-by":"crossref","unstructured":"O\u011fuzt\u00fcz\u00fcn S, Ayd\u0131n M, Demira\u011f F, Yaz\u0131c\u0131 U, \u00d6zhavzal\u0131 M, K\u0131l\u0131\u00e7 M, \u0130\u015fcan M. The expression of GST isoenzymes and p53 in non-small cell lung cancer. Folia Histochem Cytobiol 2010;48:122\u20137. doi: 10.2478\/v10042-008-0084-6","DOI":"10.2478\/v10042-008-0084-6"},{"key":"2026092522522642961_j_aiht-2026-77-4112_ref_015","doi-asserted-by":"crossref","unstructured":"Bulus H, Oguztuzun S, Guler Simsek G, Kilic M, Oguz Ada A, Gol S, Kaya Kocdogan A, Kaygin P, Bozer B, Iscan M. Expression of CYP and GST in human normal and colon tumor tissues. Biotech Histochem 2019;94:1\u20139. doi: 10.1080\/10520295.2018.1493220","DOI":"10.1080\/10520295.2018.1493220"},{"key":"2026092522522642961_j_aiht-2026-77-4112_ref_016","doi-asserted-by":"crossref","unstructured":"Takci Z, Gunes Bilgili S, Kilic M, Oguztuzun S, Bozer B, Guler Simsek G, Akbayrak A, Yildiz Seckin H, Karadag AS. Expressions of glutathione S-transferase alpha, mu, pi, and theta in the skin samples of patients with acne rosacea. J Cosmet Dermatol 2020;19:2070\u20135. doi: 10.1111\/jocd.13501","DOI":"10.1111\/jocd.13501"},{"key":"2026092522522642961_j_aiht-2026-77-4112_ref_017","doi-asserted-by":"crossref","unstructured":"Kang J, Seo DS, Ahmad Y, Park S, Yoo J, Lee J, Baek S, Joo S, Kwon H, Bae HJ, Lee H, Kwon TK, Jang Y. Biological role of cytochrome P450 family 1 subfamily A member 1 (CYP1A1) in ketogenic diet-induced modulation of lung cancer. Life Sci 2025;378:123811. doi: 10.1016\/j.lfs.2025.123811","DOI":"10.1016\/j.lfs.2025.123811"},{"key":"2026092522522642961_j_aiht-2026-77-4112_ref_018","doi-asserted-by":"crossref","unstructured":"S\u0142owikowski BK, Ga\u0142\u0119cki B, Dyszkiewicz W, Jagodzi\u0144ski PP. Decreased expression of cytochrome P450 1B1 in non-small cell lung cancer. Biomed Phar macother 2017;95:339\u201345. doi: 10.1016\/j.biopha.2017.08.056","DOI":"10.1016\/j.biopha.2017.08.056"},{"key":"2026092522522642961_j_aiht-2026-77-4112_ref_019","doi-asserted-by":"crossref","unstructured":"Jia L, Gao F, Hu G, Fang Y, Tang L, Wen Q, Gao N, Xu H, Qiao H. A novel cytochrome P450 2E1 inhibitor Q11 is effective on lung cancer via regulation of the inflammatory microenvironment. Adv Sci (Weinh) 2023;10(35):e2303975. doi: 10.1002\/advs.202303975","DOI":"10.1002\/advs.202303975"},{"key":"2026092522522642961_j_aiht-2026-77-4112_ref_020","doi-asserted-by":"crossref","unstructured":"Di Pietro G, Magno LAV, Rios-Santos F. Glutathione S-transferases: an overview in cancer research. Expert Opin Drug Metab Toxicol 2010;6:153\u201370. doi: 10.1517\/17425250903427980","DOI":"10.1517\/17425250903427980"},{"key":"2026092522522642961_j_aiht-2026-77-4112_ref_021","doi-asserted-by":"crossref","unstructured":"Okamura T, Antoun G, Keir ST, Friedman H, Bigner DD, Ali-Osman F. Phosphorylation of glutathione S-transferase P1 (GSTP1) by epidermal growth factor receptor (EGFR) promotes formation of the GSTP1\u2013c-Jun N-terminal kinase (JNK) complex and suppresses JNK downstream signaling and apoptosis in brain tumor cells. J Biol Chem 2015;290:30866\u201378. doi: 10.1074\/jbc.M115.656140","DOI":"10.1074\/jbc.M115.656140"},{"key":"2026092522522642961_j_aiht-2026-77-4112_ref_022","doi-asserted-by":"crossref","unstructured":"Wang SQ, Chen JJ, Jiang Y, Lei ZN, Ruan YC, Pan Y, Yam JWP, Wong MP, Xiao ZJ. Targeting GSTP1 as therapeutic strategy against lung adenocarcinoma stemness and resistance to tyrosine kinase inhibitors. Adv Sci (Weinh) 2023;10(7):e2205262. doi: 10.1002\/advs.202205262","DOI":"10.1002\/advs.202205262"},{"key":"2026092522522642961_j_aiht-2026-77-4112_ref_023","doi-asserted-by":"crossref","unstructured":"Bai F, Nakanishi Y, Kawasaki M, Takayama K, Yatsunami J, Pei XH, Tsuruta N, Wakamatsu K, Hara N. Immunohistochemical expression of glutathione S-transferase-Pi can predict chemotherapy response in patients with nonsmall cell lung carcinoma. Cancer 1996;78:416\u201321. doi: 10.1002\/(SICI)1097-0142(19960801)78:3<416::AID-CNCR6>3.0.CO;2-H","DOI":"10.1002\/(SICI)1097-0142(19960801)78:3<416::AID-CNCR6>3.0.CO;2-H"},{"key":"2026092522522642961_j_aiht-2026-77-4112_ref_024","doi-asserted-by":"crossref","unstructured":"Nakanishi Y, Kawasaki M, Bai F, Takayama K, Pei XH, Takano K, Inoue K, Osaki S, Hara N, Kiyohara C. Expression of p53 and glutathione S-transferase-pi relates to clinical drug resistance in non-small cell lung cancer. Oncology 1999;57:318\u201323. doi: 10.1159\/000012068","DOI":"10.1159\/000012068"},{"key":"2026092522522642961_j_aiht-2026-77-4112_ref_025","unstructured":"Crawford EL, Khuder SA, Durham SJ, Frampton M, Utell M, Thilly WG, Weaver DA, Ferencak WJ, Jennings CA, Hammersley JR, Olson DA, Willey JC. Normal bronchial epithelial cell expression of glutathione transferase P1, glutathione transferase M3, and glutathione peroxidase is low in subjects with bronchogenic carcinoma. Cancer Res 2000;60:1609\u201318. PMID: 10749130"}],"container-title":["Archives of Industrial Hygiene and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/aiht-2026-77-4112","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:52:57Z","timestamp":1790376777000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/aiht-2026-77-4112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":25,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,9,25]]},"published-print":{"date-parts":[[2026,9,1]]}},"alternative-id":["10.2478\/aiht-2026-77-4112"],"URL":"https:\/\/doi.org\/10.2478\/aiht-2026-77-4112","relation":{},"ISSN":["1848-6312"],"issn-type":[{"value":"1848-6312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]}}}